Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines
Sign Up to like & getrecommendations! Published in 2018 at "Malaria Journal"
DOI: 10.1186/s12936-018-2555-3
Abstract: BackgroundTafenoquine was recently approved for Plasmodium vivax radical cure (KRINTAFEL™) and malaria prevention (ARAKODA™).MethodsA review of the non-clinical and clinical literature was conducted to assess whether tafenoquine (and primaquine) exhibit the same neurologic lesions and… read more here.
Keywords: earlier aminoquinolines; primaquine exhibit; neurologic signs; tafenoquine primaquine ... See more keywords
Assessment of Neurologic Signs and Symptoms: Establishing a Diagnosis of Multiple Sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "The primary care companion for CNS disorders"
DOI: 10.4088/pcc.20f02871
Abstract: The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and… read more here.
Keywords: assessment neurologic; diagnosis; neurologic signs; establishing diagnosis ... See more keywords